← Back to headlines
Lexicon Pharmaceuticals to Present Phase 2b Pilavapadin Data
Lexicon Pharmaceuticals (LXRX) is scheduled to present data from its Phase 2b trial of Pilavapadin.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
